Log In
Print
BCIQ
Print
Print this Print this
 

NS2 topical

  Manage Alerts
Collapse Summary General Information
Company Aldeyra Therapeutics Inc.
DescriptionSmall molecule that traps and allows for the disposal of free aldehydes
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Dermatology (unspecified)
Indication DetailsTreat Sjogren-Larsson syndrome (SLS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today